Oncology Central

Review on the immunotherapy strategies against metastatic colorectal carcinoma

0

Colorectal cancer (CRC) is one of the most common malignancies throughout the world and the leading cause of cancer-related mortality in Western countries. Recent progress in CRC treatment options, such as surgery, chemotherapy, radiotherapy and target therapy, has improved the prognosis, but advanced disease with recurrence or distant metastasis is usually incurable and has an unfavorable prognosis.

To view restricted content, please:
Share:

Leave A Comment